Literature DB >> 23096082

Minor allele of the APOA4 gene T347S polymorphism predisposes to obesity in postmenopausal Turkish women.

Filiz Guclu-Geyik1, Altan Onat, Neslihan Coban, Evrim Komurcu-Bayrak, Vedat Sansoy, Günay Can, Nihan Erginel-Unaltuna.   

Abstract

The aim of this study was to examine the relationship between APOA4 gene T347S polymorphism with obesity measures and serum lipids in Turkish adults. Randomly selected sample of 1,554 adults (754 men, mean age 50.4 ± 11.9 years and 800 women, mean age 49.6 ± 11.8 years) were included in the study. 346 Women (43.2 %) were postmenopausal. Genotyping was performed by using hybridization probes in real-time PCR. Not men but postmenopausal women, carrying the S347 allele, were associated with 1.5 kg/m(2) higher BMI (P = 0.016) and 3.6 cm wider waist circumference (P = 0.005) than postmenopausal T347 homozygotes, controlled for covariates. Logistic regression analyses of this polymorphism, adjusted for age, fasting triglyceride, smoking status, alcohol consumption and physical activity disclosed the rare allele to be associated with obesity in postmenopausal women at an odds of 1.80 (95 % CI 1.09-2.97; P = 0.021). Serum apoB level was lower in S347 allele carriers (110.9 ± 2.9 mg/dL) than in T347 homozygotes (119.0 ± 2.4 mg/dL; P = 0.035) in men but not women. APOA4 T347S polymorphism was unrelated to lipids and other lipoproteins in either gender. The APOA4 S347 allele predisposes to obesity and high waist circumference in Turkish postmenopausal women. ApoB levels are lower only in men in S347 allele carriers.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23096082     DOI: 10.1007/s11033-012-1990-4

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  40 in total

Review 1.  The role of enterostatin and apolipoprotein AIV on the control of food intake.

Authors:  M Liu; L Shen; P Tso
Journal:  Neuropeptides       Date:  1999-10       Impact factor: 3.286

2.  APOA4 polymorphism as a risk factor for unfavorable lipid serum profile and depression: a cross-sectional study.

Authors:  Vanessa Kiyomi Ota; Elizabeth Suchi Chen; Tatiana Flank Ejchel; Tatiane Katsue Furuya; Diego Robles Mazzotti; Maysa Seabra Cendoroglo; Luiz Roberto Ramos; Lara Quirino Araujo; Rommel Rodriguez Burbano; Marília de Arruda Cardoso Smith
Journal:  J Investig Med       Date:  2011-08       Impact factor: 2.895

3.  Plasma triglycerides, an independent predictor of cardiovascular disease in men: a prospective study based on a population with prevalent metabolic syndrome.

Authors:  Altan Onat; Ibrahim Sari; Mehmet Yazici; Günay Can; Gülay Hergenç; Günsel S Avci
Journal:  Int J Cardiol       Date:  2005-08-08       Impact factor: 4.164

4.  Apolipoprotein A-IV: a protein occurring in human mesenteric lymph chylomicrons and free in plasma. Isolation and quantification.

Authors:  G Utermann; U Beisiegel
Journal:  Eur J Biochem       Date:  1979-09

5.  Genetic polymorphisms of the apolipoprotein A-IV in a Greek population and their relation to plasma lipid and lipoprotein levels.

Authors:  G Miltiadous; M Hatzivassiliou; E Bashiardes; E Bairaktari; M A Cariolou; M Elisaf
Journal:  Clin Genet       Date:  2002-09       Impact factor: 4.438

6.  Binding of human apolipoprotein A-IV to human hepatocellular plasma membranes.

Authors:  R B Weinberg; C S Patton
Journal:  Biochim Biophys Acta       Date:  1990-05-22

7.  Frequencies of apolipoprotein A4 gene polymorphisms and association with serum lipid concentrations in two healthy Spanish populations.

Authors:  A Gañán; D Corella; M Guillén; J M Ordovás; M Pocoví
Journal:  Hum Biol       Date:  2004-04       Impact factor: 0.553

8.  Association of lipoprotein(a), insulin resistance, and reproductive hormones in a multiethnic cohort of pre- and perimenopausal women (The SWAN Study).

Authors:  MaryFran Sowers; Sybil L Crawford; Jane A Cauley; Evan Stein
Journal:  Am J Cardiol       Date:  2003-09-01       Impact factor: 2.778

9.  Human apolipoprotein A-IV polymorphism: frequency and effect on lipid and lipoprotein levels.

Authors:  H J Menzel; E Boerwinkle; S Schrangl-Will; G Utermann
Journal:  Hum Genet       Date:  1988-08       Impact factor: 4.132

10.  Lipoprotein ApoC-II activation of lipoprotein lipase. Modulation by apolipoprotein A-IV.

Authors:  I J Goldberg; C A Scheraldi; L K Yacoub; U Saxena; C L Bisgaier
Journal:  J Biol Chem       Date:  1990-03-15       Impact factor: 5.157

View more
  4 in total

Review 1.  Biological underpinnings of breastfeeding challenges: the role of genetics, diet, and environment on lactation physiology.

Authors:  Sooyeon Lee; Shannon L Kelleher
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-06-28       Impact factor: 4.310

Review 2.  Apolipoprotein A-IV: a protein intimately involved in metabolism.

Authors:  Fei Wang; Alison B Kohan; Chun-Min Lo; Min Liu; Philip Howles; Patrick Tso
Journal:  J Lipid Res       Date:  2015-02-01       Impact factor: 5.922

3.  Vertical sleeve gastrectomy restores glucose homeostasis in apolipoprotein A-IV KO mice.

Authors:  Josh W Pressler; April Haller; Joyce Sorrell; Fei Wang; Randy J Seeley; Patrick Tso; Darleen A Sandoval
Journal:  Diabetes       Date:  2014-08-25       Impact factor: 9.461

4.  A long non-coding RNA, APOA4-AS, regulates APOA4 expression depending on HuR in mice.

Authors:  Wangshu Qin; Xinzhi Li; Liwei Xie; Sha Li; Jianan Liu; Linna Jia; Xue Dong; Xiaomeng Ren; Junjie Xiao; Changqing Yang; Yifa Zhou; Zheng Chen
Journal:  Nucleic Acids Res       Date:  2016-04-29       Impact factor: 16.971

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.